Chapter 2

Dysphagic patients with signs and symptoms of oropharyngeal neuromuscular impairment are indicated for receiving VitalStim® Therapy. Patients usually present with signs of aspiration, signs of muscle weakness and difficulty managing a normal diet. Typical patient categories include: Stroke. Deconditioning as a result of age or comorbidity ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download